29.03.2016 | Editorial Commentary
The promise of multiparametric imaging in oncology: how do we move forward?
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 7/2016
Einloggen, um Zugang zu erhaltenExcerpt
With the introduction of combined imaging modalities including PET/CT and more recently PET/MRI, there is strong interest in utilizing these independent modalities in a synergistic way. Up to now the field of multiparametric imaging research has mainly been driven by the MRI community. MRI offers the possibility of acquiring different sequences to visualize diverse properties of tissues (e.g. ADC mapping, T1/T2-weighted images). In the recent issues of EJNMMI there are several research papers looking into the topic of multiparametric imaging in a variety of cancer types using combined nuclear medicine imaging techniques with a different number of tracers together with advanced MR or CT imaging equipment [1‐5]. Besides MRI, other drivers beneficial for multiparametric imaging are the increased number of standardization procedures that are being rolled out. For PET [6] and also MRI [7], standardization (or harmonization) procedures are currently in place or being developed. These procedures should remove some of the uncertainties and difficulties that multicentre trials face in quantitative analysis and allow more robust quantitative imaging-derived parameters [8]. …Anzeige